Blueprint Medicines
BPMC
#2477
Rank
NZ$9.82 B
Marketcap
$153.76
Share price
1.23%
Change (1 day)
6.05%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$14.88

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$16.10. In 2022 the company made an earnings per share (EPS) of -$16.38 an increase over its 2021 EPS that were of -$19.24.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$14.88-9.15%
2022-$16.38-14.85%
2021-$19.24-297.13%
2020$9.76-176.3%
2019-$12.7935.19%
2018-$9.4638.82%
2017-$6.8247.35%
2016-$4.639.25%
2015-$4.23-31.35%
2014-$6.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.12-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.47-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.23-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA